Exercise and PTSD in Older Veterans
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02295995 |
Recruitment Status :
Completed
First Posted : November 20, 2014
Results First Posted : January 29, 2020
Last Update Posted : January 29, 2020
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Post-traumatic | Behavioral: Exercise as an Adjuvant Therapy for Veterans with PTSD | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 54 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Prevention |
Official Title: | Exercise as an Adjuvant Therapy for Veterans With PTSD |
Actual Study Start Date : | December 18, 2015 |
Actual Primary Completion Date : | May 8, 2018 |
Actual Study Completion Date : | April 15, 2019 |
Arm | Intervention/treatment |
---|---|
Experimental: Physical Activity
Participants randomized to this arm will be enrolled in a 12-week physical activity program.
|
Behavioral: Exercise as an Adjuvant Therapy for Veterans with PTSD
Methods: Approximately 50 Veterans 60 years and older with PTSD will be recruited to participate in a 12-week physical activity program consisting of aerobic and strength-training activities. Participants will be randomized to an intervention arm or usual care wait-list control. Outcomes: Changes in physical function, PTSD symptom severity, and aerobic endurance will be assessed between the two study arms. Secondary outcomes include compliance with the intervention, pain, sleep, and psychological well-being. |
No Intervention: Usual Care Wait-List
Participants randomized to this arm will continue to receive usual care services for PTSD through the Veterans Health Administration (VHA) for 12 weeks after which time they will be offered the physical activity program for 12 weeks.
|
- Feasibility of Patient Recruitment [ Time Frame: Baseline ]The primary aim/outcome of this pilot study is the feasibility of recruiting older Veterans with PTSD to participate in a 12-week exercise program. The number of Veterans recruited out of the total number contacted will be determined at baseline.
- Physical Activity [ Time Frame: Baseline and 12 Weeks ]Activity levels (metabolic equivalent [MET]-minutes/week) were measured using the Aerobic Center Longitudinal Study physical activity questionnaire.
- PTSD Symptoms [ Time Frame: Baseline and 12 Weeks ]PTSD symptom severity was assessed at both baseline and 12 Weeks using the PTSD Checklist for DSM-V (PCL-5). Scores on the PCL-5 range from 0 to 80, with higher scores indicating more severe PTSD symptoms.
- Aerobic Endurance [ Time Frame: Baseline and 12 Weeks ]Aerobic endurance was assessed using the 6-minute walk test (distance).
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 60 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Meet diagnostic criteria for current PTSD,
- live within 50 miles of Durham VA Medical Center (VAMC) and have reliable transportation,
- registered for care at the Durham VAMC,
- independently mobile (assistive devices acceptable),
- speak and write fluent conversational English
Exclusion Criteria:
- Active substance dependence other than nicotine,
- cognitive impairment, uncontrolled psychotic symptoms,
- clinical history of cardiovascular disease (CVD) occurring within the past 3 months,
- uncontrolled hypertension,
- renal disease or currently receiving dialysis,
- psychotropic medication initiated within 6 weeks prior to enrollment
- proliferative retinopathy
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02295995
United States, North Carolina | |
Durham VA Medical Center, Durham, NC | |
Durham, North Carolina, United States, 27705 |
Principal Investigator: | Katherine Shepherd Hall, PhD | Durham VA Medical Center, Durham, NC |
Documents provided by VA Office of Research and Development:
Publications of Results:
Other Publications:
Responsible Party: | VA Office of Research and Development |
ClinicalTrials.gov Identifier: | NCT02295995 |
Other Study ID Numbers: |
D1316-W 5IK2RX001316-02 ( U.S. NIH Grant/Contract ) 1IK2RX001316-01A2 ( U.S. NIH Grant/Contract ) |
First Posted: | November 20, 2014 Key Record Dates |
Results First Posted: | January 29, 2020 |
Last Update Posted: | January 29, 2020 |
Last Verified: | January 2020 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Product Manufactured in and Exported from the U.S.: | No |
Aged Exercise Veterans Adherence Clinical Trials, Randomized |